NCT00349453View on ClinicalTrials.gov

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Hemochromatosis
Interventions
DRUG

Deferiprone (L1)

50-100 mg/kg body weight daily

DRUG

Deferiprone (L1)

75 mg/kg body weight daily

DRUG

Desferrioxamine

35-50 mg/kg body weight on 2 or more days per week

Trial Locations (13)

3014

Private children's practice, Bern

3900

Private children's practice, Brig

5001

Cantonal Hospital, Children's Clinic, Aarau

Cantonal Hospital, Aarau

6826

Private practice, Riva San Vitale

6864

Private practice, Arzo

6900

Private practice, Lugano

Regional Hospital, Lugano

7000

Cantonal Hospital Graubünden, Chur

8032

University Children's Hospital, Zurich

8050

Private practice, Zürich (Kreis 11) / Oerlikon

8091

University Hospital, Zurich

9006

Children's Hospital of Eastern Switzerland, Sankt Gallen

Sponsors

Lead Sponsor

Lipomed
All Listed Sponsors
lead

Lipomed

INDUSTRY

NCT00349453 - Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients | Biotech Hunter | Biotech Hunter